We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BOQ:ASXBank of Queensland Limited Analysis

Data as of 2026-03-15 - not real-time

A$6.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Bank of Queensland (BOQ) is trading at AUD 6.80, just below its 20‑day SMA of 6.92 and marginally above the 50‑day SMA of 6.80, indicating a tight technical range. The MACD histogram is negative and the signal line is bearish, while the RSI sits at 46, suggesting neutral momentum with a slight bias to the downside. Valuation metrics are mixed: a trailing P/E of 34 far exceeds the industry average of 16, yet the discounted cash‑flow model implies a fair value of around AUD 39, pointing to a potential undervaluation gap. The stock offers a high dividend yield of 5.59%, but the payout ratio of 176% raises concerns about sustainability. Revenue is growing at 8.4% YoY and forward EPS is projected to rise to 0.576, supporting a modest earnings outlook. Volatility over the past 30 days is about 20% and the beta is low (≈0.29‑0.76), indicating limited systematic risk. Recent news provides no material catalysts, leaving the price largely driven by fundamentals and technical signals.
Overall, the combination of a strong cash position, modest earnings growth, and a potentially mis‑priced valuation makes BOQ a candidate for medium‑ to long‑term accumulation, but the current dividend sustainability and high P/E warrant caution in the short run.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and neutral RSI suggest limited upside
  • High payout ratio questions dividend reliability
  • Price near short‑term support at AUD 6.64

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 8.4% and improving forward EPS
  • DCF fair value far above current price indicating upside
  • Low beta and moderate volatility reduce market risk

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong cash reserves relative to debt
  • Regional banking niche with stable customer base
  • Attractive dividend yield if sustainability improves

Key Metrics & Analysis

Financial Health

Revenue Growth8.40%
Profit Margin8.07%
P/E Ratio34.0
ROE2.23%
ROA0.13%
P/B Ratio0.8
Op. Cash FlowA$2.9B
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI46.0
SupportA$6.64
ResistanceA$7.10
MA 20A$6.92
MA 50A$6.80
MA 200A$7.14
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$39.12
Target PriceA$6.55
Upside/Downside-3.64%
GradeUndervalued
TypeValue
Dividend Yield5.59%

Risk Assessment

Beta0.29
Volatility20.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.